Skip to main content
Date
Filter By
Home
Toggle Menu
Main navigation
Professionals
Services
Patent Prosecution
Litigation
Patent Office Litigation
Trademark & Brand Protection
Opinions & Advice
Industries
Electronics & High Tech
Biotechnology
Pharmaceuticals
Chemical & Industrial
Consumer Goods & Services
Healthcare
About
Clients
Case Studies
Awards & Recognition
Diversity & Inclusion
Our Culture
History
Office
Pro Bono
Community Engagement
In Memoriam
Contact
Careers
Lawyers, Agents & Scientists
Summer Associates
Staff
News & Insights
News
Publications
Events
Client Alerts
Newsletters
Multimedia
Subscribe
Search
Breadcrumb
Home
News & Insights
Client Alerts
Federal Circuit Grants Injunction Keeping Sandoz’s Biosimilar Version of Neupogen Off Market Until Appeal Decided
May 7, 2015
Download PDF
126.15 KB
Author(s)
Paul A. Calvo, Ph.D.
Timothy "Tim" J. Shea, Jr.